ADMP - Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q1 2022 Results - Earnings Call Transcript
Adamis Pharmaceuticals Corporation (ADMP) Q1 2022 Earnings Conference Call May 16, 2022 17:00 ET Corporate Participants Robert Uhl - ICR Westwicke Dennis Carlo - President and Chief Executive Officer David Benedicto - Chief Financial Officer Ron Moss - Chief Medical Officer David Marguglio - Chief Business Officer Conference Call Participants Presentation Operator Good evening, and welcome to the Adamis Pharmaceuticals First Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. Please note this event is being recorded. I would now like to turn the conference over to Mr. Robert Uhl with ICR Westwicke. Please go ahead. Robert Uhl Thank you, operator. Good afternoon, everyone, and welcome to the Adamis Pharmaceuticals first quarter 2022 financial results and corporate update conference call. Thank you for joining us today for the update. And welcome to our shareholders, analysts and anyone interested in Adamis. Joining me today
For further details see:
Adamis Pharmaceuticals Corporation (ADMP) CEO Dennis Carlo on Q1 2022 Results - Earnings Call Transcript